Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Nutra Pharma Corp. (NPHC) had Return on Tangible Equity of 12.17% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.39M |
|
$-2.05M |
|
$0.19M |
|
$0.20M |
|
$1.85M |
|
$-1.46M |
|
$-0.59M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-1.46M |
|
$-1.08M |
|
7.78B |
|
7.78B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.46M |
|
$0.03M |
|
$0.12M |
|
$0.58M |
|
$17.27M |
|
$0.14M |
|
$0.14M |
|
$17.41M |
|
$-16.84M |
|
$-16.83M |
|
$-16.83M |
|
7.10B |
|
| Cash Flow Statement Financials | |
$-1.16M |
|
$-0.05M |
|
$1.19M |
|
$0.04M |
|
$0.01M |
|
$-0.02M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.01 |
|
-0.58 |
|
51.03% |
|
-379.53% |
|
-379.53% |
|
-279.79% |
|
-531.37% |
|
-531.37% |
|
$-1.19M |
|
-- |
|
-- |
|
-- |
|
0.66 |
|
9.66 |
|
1.03 |
|
355.17 |
|
12.16% |
|
|
Return on Tangible Equity |
12.17% |
-350.25% |
|
12.27% |
|
$-0.00 |
|
$-0.00 |
|
$-0.00 |
|